TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,374 | -1.5% | 412 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $6,473 | -4.7% | 412 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $6,790 | +306.8% | 412 | +285.0% | 0.00% | – |
Q4 2022 | $1,669 | +66.9% | 107 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 107 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -66.7% | 107 | -74.6% | 0.00% | -100.0% |
Q1 2022 | $6,000 | +500.0% | 421 | +453.9% | 0.00% | – |
Q4 2021 | $1,000 | -85.7% | 76 | -80.9% | 0.00% | -100.0% |
Q3 2021 | $7,000 | 0.0% | 398 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $7,000 | 0.0% | 398 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $7,000 | 0.0% | 398 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $7,000 | 0.0% | 398 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $7,000 | 0.0% | 398 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $7,000 | +16.7% | 398 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $6,000 | -14.3% | 398 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $7,000 | – | 398 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |